Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $176,161
Award facts
- Contract value 100% obligated
- $176,161.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $176,161.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 26, 2026, with an ultimate completion date of January 27, 2026, was not issued under any set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will deliver pharmaceutical products and medical consumables to support Department of Defense healthcare operations, with performance occurring at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated contract SPE2DR, which was awarded in November 2025 with a $500 million ceiling and extends through December 31, 2036. The PPV-G GEN V represents part of the broader $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply chains supporting military healthcare facilities worldwide. As one of multiple regional prime vendor contractors under this program, DMS Pharmaceutical Group supplies an extensive portfolio including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to meet the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMRK?
SPE2DU26FEMRK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DU26FEMRK worth?
The government has obligated $176,161 on SPE2DU26FEMRK.
Is contract SPE2DU26FEMRK an order under another contract?
Yes. SPE2DU26FEMRK is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRK competed?
The extent of competition for SPE2DU26FEMRK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award